about
Clinical Evaluation of Specific Oral Manifestations in Pediatric Patients with Ascertained versus Potential Coeliac Disease: A Cross-Sectional Study.A point-of-care test for facing the burden of undiagnosed celiac disease in the Mediterranean area: a pragmatic design study.Celiac disease in the Mediterranean area.Renal amyloidosis in cystic fibrosis: role of colchicine therapy.Diagnosis of celiac disease and applicability of ESPGHAN guidelines in Mediterranean countries: a real life prospective studyRisk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort.Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitisThe importance of disease prevalence in assessing the diagnostic value of a test: endoscopic markers in celiac disease.Cystic Fibrosis: A Risk Condition for Renal Disease.Diagnostic Yield of 2 Strategies for Adult Celiac Disease Identification in Primary Care.Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial.C3 glomerulopathy in cystic fibrosis: a case report.Defining research priorities in cystic fibrosis. Can existing knowledge and training in biomedical research affect the choice?Case report on pathogenetic link between gluten and IgA nephropathy.Phenotype and disease course of early-onset pediatric inflammatory bowel diseaseLumacaftor/ivacaftor combination therapy for cystic fibrosis: A nationwide survey among cliniciansIleoileal Intussusceptions Caused by Eosinophilic Enteropathy
P50
Q34100778-5FE66C36-649D-45AB-9172-2FFD90A2D6ACQ34976018-219BB3C9-591C-4BA6-A205-895527085D14Q35091961-800381D4-FA15-4096-978B-623F06A82C97Q35310801-B9D935E7-35DC-4429-96AB-20AF7B8DDA65Q36256360-CC4968ED-4578-4F9D-A5E0-74A5F037EF4EQ38620025-DADD146B-2D19-425F-9A1D-8E9DC43A5E15Q39331402-54DB28C2-4FE1-4CB9-A1EB-C7BC3D9A3D85Q44798366-19B187A5-F1E4-4E43-907A-09E5BD8E2D7BQ47237478-4582C3CA-68AA-4A56-BF1D-D69D39824A8AQ47283805-C055A865-21B3-4369-AB1C-A51BE3D44C68Q47582624-CDCDDBFF-7846-4371-A68E-FF11EB8EE6A1Q52339140-1FB3C28A-44BB-40C4-B10D-C93699B19D54Q54253981-FC7099A6-724D-480D-98E8-8B619D9CBEC1Q54963030-C0214BB7-2333-4ED8-AD78-ECAE6664E48EQ56974890-47E2FA37-4E8B-4D0E-A65B-93F3C161BCBAQ58478302-F1B03BC9-7A5F-4529-9A21-DD761AA92CDDQ58478306-C9EEA371-9819-4254-8E8B-EE74D6D8C45D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stefano Costa
@ast
Stefano Costa
@en
Stefano Costa
@es
Stefano Costa
@nl
type
label
Stefano Costa
@ast
Stefano Costa
@en
Stefano Costa
@es
Stefano Costa
@nl
prefLabel
Stefano Costa
@ast
Stefano Costa
@en
Stefano Costa
@es
Stefano Costa
@nl
P106
P1153
56804330900
P21
P31
P496
0000-0001-5640-1901